|1.||Zwierz, Krzysztof: 6 articles (01/2013 - 05/2006)|
|2.||Lim, Chang-Jin: 5 articles (09/2008 - 09/2005)|
|3.||Park, Eun-Hee: 4 articles (09/2008 - 09/2005)|
|4.||McMasters, K M: 4 articles (11/2001 - 04/2000)|
|5.||Elliott, M J: 4 articles (11/2001 - 04/2000)|
|6.||Dong, Y B: 4 articles (11/2001 - 04/2000)|
|7.||Crystal, R G: 4 articles (10/2001 - 12/2000)|
|8.||Waszkiewicz, Napoleon: 3 articles (01/2013 - 08/2009)|
|9.||d'Azzo, Alessandra: 3 articles (07/2011 - 09/2004)|
|10.||Rehemtulla, Alnawaz: 3 articles (07/2010 - 02/2003)|
09/20/1999 - "Induction of cytotoxic T cells capable of lysing beta-Gal-transfected tumor cells suggests that tumor cells transduced with the bacterial beta-galactosidase gene may be eliminated in immunocompetent hosts. "
01/01/2008 - "It is shown in the present study that the basal percentage of normal prostate cells expressing senescence-associated beta-galactosidase (SA-beta-gal) is higher than that of the cancer cells. "
07/01/2007 - "Anti-tumor effects showed by in vivo studies were virtually accomplished by the frequency of induced CTLs specific to both gp70 and beta-galactosidase assessed by using pentameric assay. "
05/01/2004 - "[Study of GE7-transferring system mediated beta-galactosidase gene transfer in a rat model of ovarian tumor by intraarterial route]."
03/01/2001 - "In this study, an adenoviral vector containing the beta-galactosidase gene was instilled into the rat bladder with N-butyl-N-(4-hydroxybutyl) nitrosamine-induced tumors. "
01/01/2000 - "In in vitro studies rat pancreatic carcinoma cells (DSL-6A/C1) were transduced with replication-deficient adenovirus carrying Escherichia Coli beta-galactosidase (lacZ) gene. "
09/19/1990 - "For the study of micrometastases at their earliest stages, we transfected the lacZ gene, which codes for beta-D-galactosidase in Escherichia coli, into BALB/c 3T3 cells transformed by the Ha-ras oncogene (also known as HRAS1) of a human EJ bladder carcinoma. "
06/01/2010 - "Overexpression of miR-519a in either WI-38 or human cervical carcinoma HeLa cells triggered senescence, as measured by monitoring beta-galactosidase activity and other senescence markers. "
04/17/2008 - "We have infected p53-null H1299 human lung carcinoma cells with recombinant adenoviruses expressing WT p53, p73 or beta-galactosidase, and have undertaken microarray hybridization analyses to identify genes whose expression profile is altered by p53 or p73. "
06/01/2004 - "E6/E7 and E1/E2 transcripts were explored by RT-PCR in 53 HPV-16-positive cervical carcinomas, 39 retaining (20 European and 19 AA) and 14 having lost (12 European and 2 AA) the E1/E2 genes, and transcription repression activity of the AA E2 genes was tested in four cell lines that constitutively express the beta-galactosidase reporter or E6/E7 genes driven by the viral long control region. "
03/15/1992 - "Surface aeration and medium replenishment improved beta-galactosidase yields of a HCD culture by 20-fold (compared to a 1.6-fold improvement for a LCD culture), resulting in cultures with productivties that were independent of the cell density at infection."
03/01/1984 - "Studies of one such virus, L1GP-gal3, indicated that the synthesis of beta-galactosidase is temporally controlled beginning late (20 h) in infection after the release of infectious virus particles from the cell. "
07/04/2012 - "In order to compare the infection of HIV-1 pseudovirus to suspended and adherent cells, Tzmbl cells containing beta-gal (beta-galactosidase) reporter gene were used here to do the analysis. "
04/01/2010 - "GFP and beta-galactosidase expression was observed at 2 days post-infection and continued throughout the observation period. "
01/01/2010 - "We demonstrate here that immunizing naïve mice with low numbers of recombinant Bacille Calmette-Guérin (rBCG) expressing beta-galactosidase (beta-gal) generates predominant Th1 responses to both BCG and beta-gal whereas infection with high numbers generates a mixed Th1/Th2 response to both BCG and beta-gal. "
|4.||Lactose Intolerance (Intolerance, Lactose)
02/01/1992 - "An assessment was made of the efficacy of a beta-galactosidase, obtained from Aspergillus niger and added to intact milk, in decreasing lactose malabsorption and intolerance. "
05/01/2008 - "Application relevant studies of fungal beta-galactosidases with potential application in the alleviation of lactose intolerance."
04/01/2005 - "Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study."
04/01/2012 - "The authors concluded that these new recombinant bacteria well expressed and secreted beta-galactosidase, indicating that the beta-galactosidase expression system was successfully constructed, and this might provide a new solution for management of lactose intolerance specifically and promote the use of gene-modified organisms as part of the food-grade plasmid in general."
08/01/2010 - "Beta-galactosidase is an enzyme administered as a digestive supplement to treat lactose intolerance, a genetic condition prevalent in most world regions. "
04/01/2000 - "Dunning AT-2 cells were transduced with a retroviral vector to express beta-galactosidase, and the susceptibility of tumorigenic AT-2-lacZ cells to immunization with vaccinia-lacZ was measured using protection studies in Copenhagen and nu/nu rats. "
04/01/2000 - "Recombinant vaccinia was chosen as a prototype virus vector encoding a TAA for these studies, and beta-galactosidase was chosen as a model target TAA. "
08/01/2003 - "Here we describe the development of a novel vaccinia-neutralization assay based on the expression of a reporter gene, beta-galactosidase (beta-Gal). "
04/01/2003 - "The ability of three different viral vectors to conduct beta-galactosidase (beta-gal) gene delivery was examined: adenovirus (Ad5CMVLacZ), vaccinia (VSC9), and herpesvirus (tkLTRZ(1)). "
06/01/2002 - "We show, by in situ staining and beta-galactosidase reporter activity assay, that the adenoviral and vaccinia vectors were able to deliver the reporter gene efficiently to acinar and duct cells. "
|6.||Proteins (Proteins, Gene)
|2.||Enzyme Replacement Therapy
|3.||Heterologous Transplantation (Xenotransplantation)